Precision BioSciences, Inc.
DTIL
$4.58
-$0.135-2.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.17M | 8.62M | 16.97M | -27.67M | -61.32M |
| Total Depreciation and Amortization | 4.58M | 5.38M | 6.40M | 7.40M | 8.26M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.19M | -10.24M | -14.21M | -4.56M | 10.44M |
| Change in Net Operating Assets | -54.00M | -51.95M | -74.52M | -46.81M | -41.49M |
| Cash from Operations | -58.45M | -48.19M | -65.37M | -71.63M | -84.11M |
| Capital Expenditure | -250.00K | -127.00K | -474.00K | -1.52M | -1.96M |
| Sale of Property, Plant, and Equipment | 60.00K | 97.00K | 97.00K | 167.00K | 107.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 8.00M | 8.00M | 8.00M |
| Other Investing Activities | -25.00K | 7.95M | 7.93M | 7.88M | 7.68M |
| Cash from Investing | -215.00K | -76.00K | 7.55M | 6.52M | 5.83M |
| Total Debt Issued | 22.47M | 22.49M | -- | -- | -- |
| Total Debt Repaid | -22.51M | -22.51M | -- | -- | -- |
| Issuance of Common Stock | 50.49M | 47.38M | 43.63M | 44.78M | 5.42M |
| Repurchase of Common Stock | -- | -- | -34.00K | -34.00K | -34.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.45M | 47.36M | 43.59M | 44.74M | 5.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.21M | -903.00K | -14.22M | -20.37M | -72.90M |
